; N-[[4-(5-甲基-3-苯基-4-异恶唑基)苯基]磺酰基]丙酰胺; N-{[4-(5-甲基-3-苯基-4-异恶唑-4-基)苯基]磺酰基}丙酰胺
N-{[4-(5-Methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonyl}propanamide; N-[[4-[5-methyl-3-phenylisoxazol-4-yl]phenyl]sulfonyl]propanamide; parecoxib; N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]-propanamide; 4-[4-(N-propionylsulfamoyl)-phenyl]-5-methyl-3-phenyl-isoxazole; N-propanoyl-4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide; Propanamide, N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]-; N-[[4-[5-methyl-3-phenylisoxazol-4-yl]phenyl]sulfonyl]acetamide; Dynastat; N-[4-(5-methyl-3-phenyl-oxazol-4-yl)phenyl]sulfonylpropanamide; Parecoxib [USAN:INN:BAN]; N-((p-(5-methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)propionamide; Propanamide, N-((4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)-; SC 69124; UNII-9TUW81Y3CE; N-{[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonyl}propanamide
<0°C;避免加热
1、 摩尔折射率:97.54 2、 摩尔体积(cm3/mol):293.0 3、 等张比容(90.2K):770.0 4、 表面张力(dyne/cm):47.6 5、 极化率(10-24cm3):38.66
1.熔点(ºC):148.9~151